Provident Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Provident Investment Management, Inc.

$1.04 Billion
Q3 2024

A detailed history of Provident Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Provident Investment Management, Inc. holds 155,505 shares of VRTX stock, worth $61.8 Million. This represents 6.94% of its overall portfolio holdings.

Number of Shares

155,505

Previous 159,862 2.73%

Holding current value

$61.8 Million

Previous $74.9 Million 3.48%

% of portfolio

6.94%

Previous 7.21%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $2 Million - $2.2 Million	-4,357 Reduced 2.73%	155,505 $72.3 Million
Q2 2024 Aug 07, 2024	SELL	$392.81 - $485.53 $103,309 - $127,694	-263 Reduced 0.16%	159,862 $74.9 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $79,091 - $86,539	-194 Reduced 0.12%	160,125 $66.9 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $291,550 - $349,078	-850 Reduced 0.53%	160,319 $65.2 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $358,470 - $384,207	-1,060 Reduced 0.65%	161,169 $56 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $256,252 - $286,806	-815 Reduced 0.5%	162,229 $57.1 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $656,243 - $748,622	2,317 Added 1.44%	163,044 $51.4 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $371,488 - $417,924	-1,300 Reduced 0.8%	160,727 $46.4 Million
Q3 2022 Nov 17, 2022	SELL	$273.83 - $305.53 $2.01 Million - $2.24 Million	-7,328 Reduced 4.33%	162,027 $46.9 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $4.22 Million - $5.25 Million	-17,959 Reduced 9.59%	169,355 $47.7 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $472,731 - $557,170	2,135 Added 1.15%	187,314 $48.9 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $320,919 - $405,114	1,813 Added 0.99%	185,179 $40.7 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $1.18 Million - $1.33 Million	6,531 Added 3.69%	183,366 $33.3 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $33.2 Million - $39.1 Million	176,835 New	176,835 $35.7 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Provident Investment Management, Inc. with notifications on news.

Account

Provident Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History